FDA Commissioner Sees Innovative Pharmaceutical Manufacturing in Action at Rutgers

During visit, Congressman Frank Pallone Jr. announces legislation to expand innovative research partnerships between FDA and universities. 

Food and Drug Administration commissioner Scott Gottlieb grew up in East Brunswick and spent many weekend days at Rutgers, attending football games and other events.  On Monday, he returned to tour the Center for Structured Organic Particulate Systems (C-SOPS) at Rutgers-New Brunswick to discuss its leading role in the advancement of innovative technology in pharmaceutical production.

The center brings together engineers, scientists and industry leaders to improve the manufacturing of pharmaceuticals. Rutgers’ C-SOPS has designed and implemented continuous manufacturing methods for powder-based pharmaceutical products, a technology that enables much faster production of more reliable products through an uninterrupted process.

Click here to read more